Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Mingbing Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3372-1069; OpenAlex author ID A5042003449. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: 2 papers · 2019: 3 papers · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 16

  1. miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells. Co-author DOI 10.21037/tcr-2026-0519↗
  2. Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs. Co-author DOI 10.1002/ctm2.70354↗
  3. The mechanism by which ADAM10 cleaves Notch2 and upregulates RAB5 to regulate exosome secretion in pancreatic cancer Last author DOI 10.21203/rs.3.rs-3158671/v1↗
  4. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis. Last author DOI 10.21037/jgo-22-941↗
  5. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2. Co-author DOI 10.1016/j.cellsig.2019.109470↗
  6. Serum galectin-3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer. Last author DOI 10.1111/jcmm.15775↗
  7. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis. Last author DOI 10.7717/peerj.9301↗
  8. Characterization and proteomic profiling of pancreatic cancer-derived serum exosomes. Last author DOI 10.1002/jcb.27465↗
  9. Correlation between S100A11 and the TGF-β1/SMAD4 pathway and its effects on the proliferation and apoptosis of pancreatic cancer cell line PANC-1. Last author DOI 10.1007/s11010-018-3372-2↗
  10. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer. Last author DOI 10.1089/gtmb.2018.0235↗
  11. β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway. Co-author DOI 10.1007/s11033-018-4332-3↗
  12. S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway. Co-author DOI 10.3892/ol.2017.7295↗
  13. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.humpath.2016.07.015↗
  14. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Co-author DOI 10.1016/j.yexmp.2016.08.001↗
  15. S100 family signaling network and related proteins in pancreatic cancer (Review). Last author DOI 10.3892/ijmm.2014.1633↗
  16. High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker. Co-author DOI 10.1007/s12032-011-0058-y↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Ji · 6 shared papers, 2019–2025 · strength 0.86
  2. Dandan Jin · 5 shared papers, 2018–2025 · strength 0.74
  3. Runzhou Ni · 7 shared papers, 2012–2020 · strength 0.53
  4. Yi-Fei Ji · 4 shared papers, 2014–2022 · strength 0.37
  5. Tong Wu · 2 shared papers, 2022–2023 · strength 0.31
  6. Minxue Xu · 2 shared papers, 2020–2023 · strength 0.28
  7. Mengxiang Huang · 1 shared paper, 2026 · strength 0.26
  8. Xiaogang Hu · 1 shared paper, 2026 · strength 0.26
  9. Guoxiong Zhou · 3 shared papers, 2016–2020 · strength 0.21
  10. Ying Xiao · 2 shared papers, 2016 · strength 0.11
  11. Xiaohong Li · 2 shared papers, 2016 · strength 0.11
  12. Chunhua Wan · 2 shared papers, 2016 · strength 0.11
  13. Nan Yi · 1 shared paper, 2020 · strength 0.11
  14. Xiaolin Zhu · 1 shared paper, 2020 · strength 0.10
  15. Yihui Fan · 1 shared paper, 2020 · strength 0.10
  16. Renfang Mao · 1 shared paper, 2020 · strength 0.10
  17. Erhao Zhang · 1 shared paper, 2020 · strength 0.10
  18. Jianbo Shen · 1 shared paper, 2020 · strength 0.10
  19. Yingcheng Charles Wu · 1 shared paper, 2020 · strength 0.10
  20. Wei Wu · 1 shared paper, 2019 · strength 0.09
  21. Hongpei Wu · 1 shared paper, 2019 · strength 0.09
  22. Yu‐J. Jiao · 1 shared paper, 2019 · strength 0.09
  23. Weichang Chen · 1 shared paper, 2018 · strength 0.08
  24. Hua Huang · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.